Subscribe via RSS

Tags: acquisitionRemove, reckittRemove

M&A
Reckitt buys Paras for $726 million
As the year draws to a close, private-equity firm Actis orchestrates the sale of its portfolio company Paras Pharmaceuticals in India to Reckitt Benckiser for $726 million.
By Sameera Anand | 14 December 2010
| Next »
Tag Filters
MOST READ
Polls
What is your outlook on China?
   |   View results
Long-term bullish, I'm buying on the dips
  46%
 
Cautious
  34%
 
Expecting a hard landing
  20%
TOTAL VOTES: 79

 
View previous polls »
LATEST FROM AsianInvestor
Latest headlines from AsianInvestor
More from AsianInvestor »
WEBCASTS
On Demand Webcasts
View all webcasts »
Tables
Latest League Tables » Dealogic
DCM | ECM | M&A | Fees
Debt Pipeline »
Equity Pipeline »
Magazine
FinanceAsia Magazine
FinanceAsia
May 2012